Why is Remus Pharma. falling/rising?

As of 18-Jul, Remus Pharmaceuticals Ltd is experiencing a price increase, with its current price at 978.75, reflecting a rise of 65.85 or 7.21%. The stock has outperformed its sector today by 7.76%, and its delivery volume has increased significantly, rising by 61.02% compared to the 5-day average. In terms of returns, the stock has shown a positive performance over the past week and month, with increases of 5.16% and 5.62%, respectively, although it remains down 21.62% year-to-date. The stock is currently trading above its 5-day, 20-day, and 50-day moving averages, indicating a short-term upward trend, though it is still below its 100-day and 200-day moving averages. There is no information available regarding positive or negative factors that could further explain the stock's recent movement.
Broader market context indicates that while Remus Pharmaceuticals has performed well in the short term, the benchmark Sensex has seen a decline of 0.72% over the past week and a modest increase of 0.63% over the past month. This suggests that the stock's recent rise is not entirely reflective of broader market trends, as it has managed to gain traction despite the benchmark's performance. Year-to-date, the stock has underperformed significantly compared to the Sensex, which has increased by 5.60%, highlighting a contrasting trajectory between the company and the overall market.